Related Experiment Video
Updated: Jul 7, 2026

10:04
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model
Jing Zhao1, Xiaoning Wang2, Huachao Zhu2
1Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, People's Republic of China. zhaojing0922@xjtu.edu.cn.
Clinical and Experimental Medicine
|April 18, 2024
Summary
This study identifies natural killer (NK) cell biomarkers to predict multiple myeloma (MM) progression. A validated prognostic model aids in predicting patient outcomes and guiding immunotherapy strategies.
Area of Science:
- Immunology
- Oncology
- Bioinformatics
Background:
- Natural killer (NK) cells are implicated in the progression of multiple myeloma (MM).
- Identifying NK cell-related biomarkers is crucial for understanding MM pathogenesis.
Purpose of the Study:
- To elucidate the correlation between NK cells and MM progression.
- To identify novel NK cell-related biomarkers for MM prognosis.
- To develop a prognostic model for predicting patient outcomes and immunotherapy response.
Main Methods:
- Single-cell transcriptome analysis including cell annotation, communication, and pseudotime analysis.
- Gene Ontology, KEGG, and PPI network analyses for NK-related differentially expressed genes (DEGs).
- Construction and validation of a prognostic risk model using Cox and LASSO regression.
Main Results:
- Identification of 8 NK-related DEGs from 123 PPI network genes.
- Development of a validated prognostic model for MM.
- Significant differences in immune cell infiltration between high- and low-risk groups.
Conclusions:
- A novel prognostic model associated with NK cells for MM has been developed and validated.
- The model offers insights into predicting patient outcomes and immunotherapy response.
- Potential drug targets for enhancing immunotherapy efficacy in MM were identified.

